Skip to main content

Table 8 High impact variants with increased allele frequency in Oncopig HCC tumor compared to cell line

From: Development of a whole-exome sequencing kit to facilitate porcine biomedical research

Gene

Variant type

VAF in Oncopig HCC cell line

Highest VAF in a region of the Oncopig HCC tumor

ATAD2

INDEL: frameshift

0.071

0.333

BCL9

SNV: stop gain

0.010

0.047

CCDC47

SNV: stop gain

0.016

0.037

CP

INDEL: frameshift

0.05

0.125

DBF4

INDEL: frameshift

0.007

0.053

DTNA

SNV: splice acceptor

0.010

0.033

ENSSSCG00000033117

SNV: stop gain

0.020

0.034

ENSSSCG00000033287

INDEL: frameshift

0.423

0.556

ENSSSCG00000042907

INDEL: frameshift

0.009

0.066

FGF23

INDEL: frameshift

0.042

0.152

GFM2

SNV: stop gain

0.013

0.042

IFIT1

INDEL: frameshift

0.019

0.083

IRF2BP1

INDEL: frameshift

0.029

0.066

LRRC10B

INDEL: frameshift

0.033

0.046

MICU3

INDEL: frameshift

0.079

0.154

MSRB1

SNV: stop gain

0.015

0.048

MTCL1

SNV: stop gain

0.009

0.016

NID1

SNV: stop gain

0.008

0.016

NSUN5

SNV: splice acceptor

0.025

0.029

OR51B2

SNV: stop gain

0.208

0.396

PCDHAC2

SNV: splice donor

0.045

1.00

PRUNE2

INDEL: frameshift

0.063

0.231

QRICH1

SNV: stop gain

0.002

0.010

RDX

INDEL: frameshift

0.031

0.109

THBS3

SNV: stop gain

0.013

0.017

TP53BP1

SNV: stop gain

0.012

0.019

URB2

SNV: stop gain

0.013

0.014

ZMYM6

SNV: stop gain

0.010

0.048

ZWINT

SNV: splice acceptor

0.010

0.032

  1. HCC hepatocellular carcinoma, VAF variant allele frequency, INDEL insertion and deletion, SNV single nucleotide variant